[3/9 held] AI-based support tool for new strategy formulation "Word ATLAS" -Non-biased competitive analysis and visualization of KOL trends-
We often ask about the following dilemmas and needs.
(XNUMX) KOL analysis relies on external surveys and has become a snapshot type (spot) analysis in a predetermined area.
(XNUMX) I want to comprehensively, objectively and timely grasp the quality and quantity of papers related to products.
③ I want to know not only the product but also the area and the momentum of KOL.
(XNUMX) I would like to comprehensively and objectively look at the KOL-related values on a performance-based basis (thesis-based).
◆ Theme: "Word ATLAS", a support tool for new strategy formulation utilizing AI-Visualization of competitive analysis and KOL trends without bias-
◆ Date: September 2022, 3 (Wednesday) 9: 17-00: 17
(XNUMX) Market trends related to medical DX
② FRONTEO's AI solutions in general
③Introduction of Word ATLAS
④ QA
・ Persons in charge of R & D, Business Development Department, Marketing Department, etc.
・ Those who want to realize new strategy formulation by utilizing AI
Please refrain from applying for those who use free addresses, those who are in the same industry as our company, or those whose affiliation is unknown.When accessing ZOOM on the day of the event, please enter the name and email address you provided when you applied for the ZOOM participation input field.
Tomoya Ohsumi
After joining IQVIA in 2006, after working in a sales position (MR), he became a project manager, group manager, and new business development manager.He is in charge of marketing, training, consulting and medical related projects with a focus on oncology.He is involved in launching new businesses and organizational reforms such as oncology MRs, MSLs, and clinical educators. From 2019, he will launch a new service for patients as the person in charge of new business development of the patient support program. He received a Master of Business Administration (MBA) from Waseda University Business School in 2020.While in school, he conducted quantitative research on the clinical development of prescription drugs and wrote a master's thesis.
Joined FRONTEO in 2021 and became the head of the medical DX team of the Life Science AI Business Headquarters. Challenge to solve medical problems by utilizing AI.
Yukari Oda
After serving as a manager in the food industry, such as store management, he entered the healthcare industry.He is involved in the sales of drugs and infusions at multiple pharmaceutical companies.He has experienced a wide range of disease areas such as cardiovascular, respiratory, skin and metabolic endocrine areas. He joined FRONTEO and is currently proposing AI solutions mainly to pharmaceutical companies.
Articles in the same category
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>
[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective
[3/13 31st Economic Security Study Session] Strategic importance of “India” towards the post-China era
[Webinar held on 3/12] Learning from court precedents: “Initial response and legal measures in cases of trade secrets taken out by retired employees”